中文 | English
R&D Centre
About Us
Board of Directors
Milestones
Manufacturing facility
R&D Centre
Certification
Contact us
Supply of APIs and Formulations
Joint Development
Contract Manufacturing
Location
R&D Centre

1.Consist of two R&D Department (DepartmentⅠis situated in Xinchang and DepartmentⅡis situated at Zhangjiang in Shanghai)

2.Highly experienced team with more than 120 members

3.Ability to develop products and file ANDAs/dossiers in regulated markets like US, Canada, Europe, and other countries

4.Established Postdoctoral Scientific Research Workstation

5.Facilities that meet global standard

6、Establish good partnership for developing new drugs with Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences and Medicinal Biotech Institute, Chinese Academy of Medical Sciences, Zhejiang University, East China University of Science and Technology, Zhejiang University of Technology, University of Science and Technology of China, China Pharmaceutical University.


7、R&D Focusing on:Novelty and Generic drugs for anti-infective, cardiovascular and cerebrovascular diseases(hypertension, hyperlipemia, hyperglycemia,antiplatelet coagulating), central nervous system(Antidepressant, Antipsychotic, Antiparkinsonian,anti-Alzheimer's disease, Sedative-hypnotic, Anticonvulsant).

8、Successful case

Three years ago, Jingxin began Co-operation with German and British partners to develop Generic drugs(including API) , several of them have been successfully registered for marketing now. Recently, Jingxin signed an collaboration agreement with a German company, which grants Jingxin exclusive rights to develop and market a novel potential drug for insomnia in China.